Obesity. Overweight and obesity
Conditions
Interventions
Intervention 1: Intervention group:. Intervention 2: Control group:.
Sponsors
Tehran University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: Informed consent of the patient BMI lower than 39.9 and higher than 25 Age between 18 and 65 years
Exclusion criteria
Exclusion criteria: Suffering from incurable diseases Suffering from liver and kidney diseases Simultaneous use of slimming drugs Taking anticoagulants such as aspirin, warfarin and clopedogrel
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Weight. Timepoint: The effect of the drug on the patient's weight is measured once every two weeks. Method of measurement: Weighing with scales. | — |
Secondary
| Measure | Time frame |
|---|---|
| Appetite. Timepoint: once every two weeks. Method of measurement: Asking the individual - Likert scale. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMahdi Vazirian
Tehran University of Medical Sciences
Outcome results
None listed